Journal profile · Immunology
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
ISSN 1532-1819 · eISSN 1532-4230 · Taylor and Francis Ltd. · UNITED STATES · Quarterly · Founded 2001
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY: subscription journal; APC charged, amount not published; review about 59 days (first decision after review, publisher); community-reported acceptance: easy; 38 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY is published by Taylor and Francis Ltd.. By OpenAlex counts of its recent articles, its largest topics are Advanced Biosensing Techniques and Applications, Monoclonal and Polyclonal Antibodies Research and Clinical Laboratory Practices and Quality Control, together about 37.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Immunoassay & Immunochemistry (JII) is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of human immunoassay and immunochemistry, as well as selected aspects of immunology. JII publishes Research Articles, Review Articles, and Letters to the Editor and welcomes research on receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, in vivo and in vitro diagnostic reagents and techniques, molecular analyses, point-of-care testing, clinical immunology and biomarkers in clinical trials, antibody isolation and purification, diagnosis of viral diseases, and vaccines and immunotherapies, among other topics. Readership includes immunochemists, clinical immunologists, molecular biologists, clinical chemists, clinical diagnosticians, toxicologists, forensic scientists, allergists, pathologists, oncologists, epidemiologists, and infectious disease clinicians and scientists. We do not consider research on veterinary and/or avian topics. Authors wishing to submit to JII should review the Instructions for Authors. Further guidance can be found on our Author Services webpage. Peer Review Policy: All submitted manuscripts are subject to initial appraisal by the Editor-in-Chief, and, if found suitable for further consideration, to rigorous and rapid peer review by independent, anonymous expert referees. All peer review is double anonymized. Publishing Ethics Statement: The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of Committee of Publication Ethics (COPE) and utilizes Similarity Check via CrossRef for all journals. More information on our ethical standards and policies can be found here: http://authorservices.taylorandfrancis.com/ethics-for-authors/. Appeals and Complaints Policy: The Journal has an appeals and complaints policy which can be viewed here: https://authorservices.taylorandfrancis.com/peer-review-appeals-and-complaints-from-authors/.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Miriam MoscovitchPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Biosensing Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology14.4%
- Monoclonal and Polyclonal Antibodies ResearchMedicine13.3%
- Clinical Laboratory Practices and Quality ControlMedicine9.6%
- Biosensors and Analytical DetectionEngineering6.3%
- Hepatitis C virus researchMedicine4.7%
- Hepatitis B Virus StudiesMedicine4.6%
- Pharmacological Effects and AssaysAgricultural and Biological Sciences4.3%
- Systemic Lupus Erythematosus ResearchMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Medical Laboratory Technology | Q2 | 21/42 | 51st |
| Immunology and Allergy | Q4 | 178/234 | 23rd |
| Immunology | Q4 | 191/243 | 21st |
| Clinical Biochemistry | Q4 | 100/124 | 19th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASPublisher website
Other: ProQuest, OCLC, Adis International Ltd. Reactions Weekly, AIDS & Cancer Research, EBSCOhost (various), Genamics JournalSeek, International Atomic Energy Agency INIS Collection Search, OCLC ArticleFirst Electronic Collections Online, ProQuest (various), Royal Society of Chemistry Analytical Abstracts
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher) 2025
- 2.2Publisher website ·
- SJR 2026-06
- 0.27LetPub ·
- SJR (publisher) 2025
- 0.27Publisher website ·
- SNIP 2026-06
- 0.36LetPub ·
- SNIP (publisher) 2025
- 0.36Publisher website ·
- h-index
- 24LetPub ·
- h-index
- 35OpenAlex ·
- i10-index
- 315OpenAlex ·
- 2-year mean citedness
- 0.97OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 36LetPub ·
- Downloads per year (publisher)
- 33,000Publisher website ·
Articles by year OpenAlex count · 1,031 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 2 | 443 |
| 2025 | 38 | 2 | 666 |
| 2024 | 39 | 1 | 853 |
| 2023 | 26 | 4 | 837 |
| 2022 | 39 | 2 | 867 |
| 2021 | 54 | 3 | 797 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
59 daysfirst decision after review · community reports over 12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 29%Publisher website ·
- Submission to first decision
- 28 daysPublisher website ·
- First decision after review
- 59 daysPublisher website ·
- Acceptance to publication
- 14 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- research on veterinary and/or avian topics
Article types accepted3
- letters to the editorJII publishes Research Articles, Review Articles, and Letters to the EditorLength not stated
- research articlesJII publishes Research Articles, Review Articles, and Letters to the EditorLength not stated
- review articlesJII publishes Research Articles, Review Articles, and Letters to the EditorLength not stated
Policy excerpts from the journal's websitePublication ethics, Open access, Peer review
- Publication ethics
COPE member, Similarity Check via CrossRef Model summary
Publishing Ethics Statement: The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of Committee of Publication Ethics (COPE) and utilizes Similarity Check via CrossRef for all journals.
Source ↗Publisher website ·- Open access Open access
Journal of Immunoassay and Immunochemistry is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the …
Source ↗Publisher website ·- Peer review
Double anonymized peer review Model summary
Peer Review Policy: All submitted manuscripts are subject to initial appraisal by the Editor-in-Chief, and, if found suitable for further consideration, to rigorous and rapid peer review by independent, anonymous expert referees. All peer review is double anonymized.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Frequency
- Quarterly
- Founded
- 2001
- ISSN
- 1532-1819
- Electronic ISSN
- 1532-4230
- Latest issue on the website
- Volume 47, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
How long does peer review take at JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY?
The publisher reports about 59 days (first decision after review); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 29%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY?
According to LetPub and DOAJ records, JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY is indexed in Scopus. The journal's website also lists MEDLINE, PubMed, Embase and CAS; that list has not been checked against each database.
Is JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY open access, and what is the APC?
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .